Literature DB >> 21366813

Use of metformin in pediatric age.

Claudia Brufani1, Danilo Fintini, Valerio Nobili, Patrizia Ippolita Patera, Marco Cappa, Mario Brufani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21366813     DOI： 10.1111/j.1399-5448.2010.00741.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN： 1399-543X            Impact factor:   4.866


× No keyword cloud information.
  9 in total

Review 1.  Evolving Pharmacotherapeutic Strategies for Type 1 Diabetes Mellitus.

Authors:  Samie Sabet; Michelle E Condren; Angela F Boston; Lauren C Doak; Laura J Chalmers
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Sep-Oct

2.  Brief Report: Metformin for Antipsychotic-Induced Weight Gain in Youth with Autism Spectrum Disorder.

Authors:  Logan K Wink; Ryan Adams; Ernest V Pedapati; Kelli C Dominick; Emma Fox; Catherine Buck; Craig A Erickson
Journal:  J Autism Dev Disord       Date:  2017-07

3.  Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands.

Authors:  S Fazeli Farsani; P C Souverein; J A Overbeek; M M J van der Vorst; C A J Knibbe; R M C Herings; A de Boer; A K Mantel-Teeuwisse
Journal:  Br J Clin Pharmacol       Date:  2015-05-20       Impact factor: 4.335

4.  Pharmacokinetics of metformin in girls aged 9 years.

Authors:  David Sánchez-Infantes; Marta Díaz; Abel López-Bermejo; María Victoria Marcos; Francis de Zegher; Lourdes Ibáñez
Journal:  Clin Pharmacokinet       Date:  2011-11-01       Impact factor: 6.447

5.  Childhood obesity.

Authors:  Anju Seth; Rajni Sharma
Journal:  Indian J Pediatr       Date:  2012-12-21       Impact factor: 1.967

6.  Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study.

Authors:  Y E Lentferink; M P van der Aa; E G A H van Mill; C A J Knibbe; M M J van der Vorst
Journal:  Nutr Diabetes       Date:  2018-09-10       Impact factor: 5.097

Review 7.  The Causes of Insulin Resistance in Type 1 Diabetes Mellitus: Is There a Place for Quaternary Prevention?

Authors:  Marta Wolosowicz; Bartlomiej Lukaszuk; Adrian Chabowski
Journal:  Int J Environ Res Public Health       Date:  2020-11-21       Impact factor: 3.390

8.  Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods.

Authors:  Gloria M Reeves; Courtney Keeton; Christoph U Correll; Jacqueline L Johnson; Robert M Hamer; Linmarie Sikich; Lindsey Hazzard; Cheryl Alderman; Abigail Scheer; Micah Mabe; Sandeep Kapoor; Eva Sheridan; Irmgard Borner; Kristin Bussell; Sara Pirmohamed; Terrence C Bethea; Raja Chekuri; Rhoda Gottfried; Shauna P Reinblatt; Erin Santana; Mark A Riddle
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2013-08-15       Impact factor: 3.033

9.  No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study.

Authors:  Hanne Strøm; Randi Selmer; Kåre I Birkeland; Henrik Schirmer; Tore Julsrud Berg; Anne Karen Jenum; Kristian Midthjell; Christian Berg; Lars Christian Stene
Journal:  BMC Public Health       Date:  2014-05-29       Impact factor: 3.295
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.